Clinical Trials Logo

Clinical Trial Summary

Aplastic anemia is a condition in which the cells normally found in blood are greatly decreased. The normal levels of white blood cells, red blood cells, and platelets are much lower in patients with aplastic anemia.

Because of these low levels of blood cells, patients with aplastic anemia have a variety of immune system abnormalities. However, low levels of blood cells make it difficult to collect specialized white blood cells (mononuclear cells) for research studies.

This study was designed to collect lymphocytes from patients with low levels of all blood cells (pancytopenia) for use in research. Patients participating in the study will undergo a special procedure known as lymphapheresis. During lymphapheresis blood is taken from the patient in a manner similar to blood donation. The white blood cells are selectively removed by spinning (centrifugation), and the remaining red blood cells and platelets are placed back (re-infused) into the donor s blood stream.

Patients participating in this study will not benefit directly from it. However, cells collected in this study may increase scientific knowledge and improve understanding and treatment for diseases like aplastic anemia.


Clinical Trial Description

Patients with aplastic anemia, myelodysplasia, and other marrow failure syndromes have a variety of immunologic abnormalities including lymphocyte phenotypic and lymphokine production dysregulation. Because of their low blood counts, it has been difficult to obtain sufficient peripheral blood mononuclear cells for research studies. Patients agreeing to this protocol will be lymphapheresed the equivalent of one or two units of cells (approximately 1-2 x 10(8) cells), which will be used for research purposes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00001214
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date April 30, 1986
Completion date August 17, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05473650 - Spectrum of Hematological Disorders in Pediatrics
Completed NCT00001398 - Stem Cell Factor Medication for Aplastic Anemia Phase 1
Completed NCT00260689 - Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia Phase 2
Completed NCT00000597 - Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders Phase 3
Not yet recruiting NCT03521947 - Management of Childhood Pancytopenia
Completed NCT00001399 - Gene Therapy for the Treatment of Fanconi's Anemia Type C Phase 1
Completed NCT01193283 - Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia Phase 1/Phase 2
Completed NCT01187017 - A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia Phase 1/Phase 2